Genmab reported 4M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US $ 328M 33M
Biomarin Pharmaceutical BMRN:US $ 3.86M 0.05M
Fresenius Medical Care FME:GR € 85M 1.79M
Genmab GEN:DC 4M 1000K
Immunogen IMGN:US $ 1.08M 0.17M
Insmed INSM:US $ 3.36M 66K
Lonza Group LONN:SW 28M 2M
Novartis NOVN:VX 202M 1000K
Regeneron Pharmaceuticals REGN:US $ 13.1M 0.5M